研究業績

研究業績2021年度　英文

詳細

研究業績2021年度　英文（原著、総説、症例報告）

 

  1. Adams D., Ando Y., Beirão JM, Coelho T., Gertz MA., Gillmore JD., Hawkins PN., Lousada I., Suhr OB., Merlini G. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. 2021;268:2109-2122

 

  1. Benson MD, Berk JL, Dispenzieri A, Damy T, Gillmore JD, Hazenberg BP, Lavatelli F, Picken MM, Röcken C, Schönland S, Ueda M, Westermark P. Tissue biopsy for the diagnosis of amyloidosis: experience from some centres. Amyloid, 2022;29:8-13

 

 

  1. Coelho T., Ando Y., Benson MD., Berk JL., Waddington-Cruz M., Dyck PJ., Gillmore JD., Khella SL., Litchy WJ., Obici L., Monteiro C., Tai LJ., Viney NJ., Buchele G., Brambatti M., Jung SW., St L O’Dea L., Tsimikas S., Schneider E., Geary RS., Monia BP., Gertz M. Design and rationale of the global phase 3 NEURO-TTRansform study of antisense oligonucleotide AKCEA-TTR-L (Rx) (ION-682884-CS3) in hereditary transthyretin-mediated amyloid Polyneuropathy. Neurol Ther. 2021;10:375-389

 

  1. Dorbala S., Ando Y., Bokhari S, Dispenzieri A., Falk RH., Ferrari VA., Fontana M., Gheysens O., Gillmore JD., Glaudemans AWJM., Hanna MA., Hazenberg BPC., Kristen AV., Kwong RY., Maurer MS., Merlini G., Miller EJ., Moon JC., Murthy VL., Quarta CC., Rapezzi C., Ruberg FL., Shah SJ., Slart RHJA., Verberne HJ., Bourque JM. Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2021;28:1761-1762

 

  1. Dorbala S., Ando Y., Bokhari S, Dispenzieri A., Falk RH., Ferrari VA., Fontana M., Gheysens O., Gillmore JD., Glaudemans AWJM., Hanna MA., Hazenberg BPC., Kristen AV., Kwong RY., Maurer MS., Merlini G., Miller EJ., Moon JC., Murthy VL., Quarta CC., Rapezzi C., Ruberg FL., Shah SJ., Slart RHJA., Verberne HJ., Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2-diagnostic criteria and appropriate utilization. Circ Cardiovasc Imaging. 2021;14,e000030

 

  1. Dorbala S., Ando Y., Bokhari S., Dispenzieri A., Falk RH., Ferrari VA., Fontana M., Gheysens O, Gillmore JD., Glaudemans AWJM., Hanna MA., Hazenberg BPC., Kristen AV., Kwong RY., Maurer MS, Merlini G., Miller EJ., Moon JC., Murthy VL., Quarta CC., Rapezzi C., Ruberg FL., Shah SJ., Slart RHJA., Verberne HJ., Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging. Circ Cardiovasc Imaging. 2021;14:e000029

 

  1. Dorbala S., Ando Y., Bokhari S., Dispenzieri A., Falk RH., Ferrari VA., Fontana M., Gheysens O., Gillmore JD., Glaudemans AWJM., Hanna MA., Hazenberg BPC., Kristen AV., Kwong RY., Maurer MS., Merlini G., Miller EJ., Moon JC., Murthy VL., Quarta CC., Rapezzi C., Ruberg FL., Shah SJ., Slart RHJA., Verberne HJ., Bourque JM. Addendum to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2021;28:1769-1774

 

  1. Dorbala S., Ando Y., Bokhari S., Dispenzieri A., Falk RH., Ferrari VA., Fontana M., Gheysens O., Gillmore JD., Glaudemans AWJM., Hanna MA., Hazenberg BPC., Kristen AV., Kwong RY., Maurer MS., Merlini G., Miller EJ., Moon JC., Murthy VL., Quarta CC., Rapezzi C., Ruberg FL., Shah SJ., Slart RHJA., Verberne HJ., Bourque JM. Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. J Nucl Cardiol. 2021;28:1763-1767

 

  1. Fujimoto T, Yamano T, Miyagawa-Hayashino A, Naiki,H, Ueda M, Tasaki M, Yamano M, Zen K, Numata S, Matoba S. A case with transthyretin amyloid cardiomyopathy complicated with rapidly progressive aortic stenosis possibly caused by amyloid deposition in the aortic valve. Circ Cardiovasc Imaging. 2021;14:e013357

 

  1. Harada S, Inatomi Y, Nakajima M, Nakane S, Matsubara S, Takamatsu K, Yonehara T. Asymmetrical manifestation of faciobrachial dystonic seizures in leucine-rich, glioma-inactivated 1 antibody encephalitis: a case report. Clin Exp Neuroimmunol. 2021;12:135-139

 

  1. Hayashi H, Oda S, Kidoh M, Jyo A, Kobayashi N, Okada Y, Matsubara S, Ueda M, Hirai T. Multiparametric cardiac magnetic resonance imaging of cardiac involvement associated with sporadic inclusion body myositis. Circ Cardiovasc Imaging. 2021;14:1155-1156

 

  1. Ikura H, Kitakata H, Endo J, Moriyama H, Sano M, Tsujikawa H, Sawano M, Masuda T, Ohki T, Ueda M, Kosaki K, Fukuda K. Three patients of transthyretin amyloidosis in a Japanese family with amyloidogenic transthyretin Thr49Ser (p.Thr69Ser) variant. Eur J Med Genet. 2022;65:104451

 

  1. Inatomi Y, Nakajima M, Ikeda T, Yonehara T, Terasaki T, Hashimoto Y, Kouzaki Y. Clinical characteristics of patients with ischemic stroke after the 2016 Kumamoto earthquake, a multi-center study. Neurol Sci. 2021;42:5055-5063

 

  1. Inatomi Y, Nakajima M, Yonehara T. Aphasia induced by infratentorial ischemic stroke: two case reports. Cogn Behav Neurol. 2021;34:129-139

 

  1. Inomata T, Tahara N, Nakamura K, Endo J, Ueda M, Ishii T, Kitano Y, Koyama J. Diagnosis of wild-type transthyretin amyloid cardiomyopathy in Japan: red-flag symptom clusters and diagnostic algorithm. ESC Heart Fail. 2021;8:2647-2659

 

  1. Inoue Y, Masuda T, Misumi Y, Ando Y, Ueda M. Metformin attenuates vascular pathology by increasing expression of insulin-degrading enzyme in a mixed model of cerebral amyloid angiopathy and type 2 diabetes mellitus. Neurosci Lett. 2021;762:136136

 

  1. Inoue Y, Ando Y, Misumi Y, Ueda M. Current management and therapeutic strategies for cerebral amyloid angiopathy. Int J Mol Sci. 2021;22:3869

 

  1. Kakimoto A, Ishizaki M, Ueyama H, Maeda Y, Ueda M. Renal function in amyotrophic lateral sclerosis patients on long-term treatment with edaravone. Medicine. 2021;100:e26127

 

  1. Kano Y., Mizuta I., Ueda A., Nozaki H., Sakurai K., Onodera O., Ando Y., Yamada K., Yuasa H., Mizuno T. Heterozygous cysteine-sparing NOTCH3 variant p.Val237Met in a Japanese patient with suspected cerebral autosomal dominant arteriopathy with subcortical infarcts and Leukoencephalopathy: A Case Report. Intern med. 2021;60:2479-2482

 

  1. Maeda K, Kubota Y, Kitagawa S, Ueda M, Ando Y, Ito Y. The prostate as a good candidate organ for proving amyloid deposition in non-endemic late onset hereditary transthyretin amyloidosis: Report of two cases. J Neurol Sci. 2021;424:117418

 

  1. Matsushita H, Isoguchi A, Okada M, Masuda T, Misumi Y, Tsutsui C, Yamaguchi N, Ichiki Y, Sawashita J, Ueda M, Mizuguchi M, Ando Y. Glavonoid, a possible supplement for prevention of ATTR amyloidosis. Heliyon. 2021;7:e08101

 

  1. Misumi I, Fukushima M, Wada K, Urata J, Sato K, Nagano M, Tsujita K. A case of malignant hypertension with multi-organ injury. Radiol Case Rep. 2021;17:455-461

 

  1. Nakahara K, Nakane S, Nagaishi A, Narita T, Matsuo H, Ando Y. Very late onset neuromyelitis optica spectrum disorders. Eur J Neurol. 2021;28:2574-2581

 

  1. Nakajima M, Inatomi Y, Ueda A, Ito Y, Kouzaki Y, Takita T, Wada K, Yonehara T, Terasaki T, Hashimoto Y, Ando Y. Preceding direct oral anticoagulant administration reduces the severity of stroke in patients with atrial fibrillation – K-PLUS Registry. J Clin Neurosci. 2021;89:106-112

 

  1. Nakajima M, Uyama E, Suga T, Honda S, Ando Y. Deep venous thrombosis in patients with neurological disease: A multicenter, prospective study. J Clin Neurosci. 2021;91:214-218

 

  1. Nakashima N, Takashio S, Morioka M, Nishi M, Hirakawa K, Hanatani S, Masuda T, Ueda M, Tsujita K. Preclinical diagnosis of wild-type transthyretin amyloid cardiomyopathy in a patient undergoing carpal tunnel release. J Cardiol Cases. 2021;24:250-253

 

  1. Nishida-Fukuda H., Tokuhiro K., Ando Y., Matsushita H., Wada M., Tanaka H. Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines. PLoS One. 2021;16:e0249912

 

  1. Nogueira RG, Terasaki T(78th), Sugimura Y(148th), et al. SVIN COVID-19 global registry Global impact of COVID-19 on stroke care.Int J Stroke. 2021;16:573–584

 

  1. Nogueira RG, Terasaki T(82nd), Sugimura Y(92nd), et al. on behalf of the SVIN COVID- 19 Global Stroke Registry. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis.Neurology. 2021;96:e2824–e2838

 

  1. Ohya Y, Tasaki M, Hayashida S, Katayama N, Tsuchida T, Kuriwaki K, Ueda M, Inomata Y. Carpal tunnel syndrome due to iatrogenic amyloidosis after domino liver transplantation from hereditary transthyretin amyloidosis: a case report. Transplant Proc. 2021;53:1313-1316

 

  1. Oike F, Usuku H, Yamamoto E, Yamada T, Egashira K, Morioka M, Nishi M, Komorita T, Hirakawa K, Tabata N, Yamanaga K, Fujisue K, Hanatani S, Sueta D, Arima Y, Araki S, Takashio S, Oda S, Misumi Y, Kawano H, Matsushita K, Ueda M, Matsui H, Tsujita K. Prognostic value of left atrial strain in patients with wild-type transthyretin amyloid cardiomyopathy. ESC Heart Fail. 2021;8:5316-5326

 

  1. Okada M, Misumi Y, Masuda T, Takashio S, Tasaki M, Matsushita H, Ueda A, Inoue Y, Nomura T, Nakajima M, Yamashita T, Shinriki S, Matsui H, Tsujita K, Ando Y, Ueda M. Plasma growth differentiation factor 15: A novel tool to detect early changes of hereditary transthyretin amyloidosis. ESC Heart Fail. 2021;8:1178-1185

 

  1. Onishi H, Yamamura O, Tsubouchi H, Hirobe T, Kosugi I, Enomoto S, Yamamoto T, Daitoku S, Satou N, Chiba H, Kai Y, Hashimoto Y, Hamano T, Terasawa H. Hypertension treatment status and ultrasonic cardiopathy findings in temporary housing residents after the Kumamoto earthquake: a cross-sectional study. Arterial Hypertens. 2021;25:69-76

 

  1. Singu T, Nakajima M, Ueda A, Nakahara K, Nomura T, Kojima S, Inoue T, Ueda M. Transient optic neuritis and perineuritis associated with anti-MOG antibody after SARS-CoV-2 mRNA vaccination. Neuroimmunol Rep. 2022;2:100077

 

  1. Suda S, Abe A, Iguchi Y, Yagita Y, Kanzawa T, Okubo S, Ohara N, Mizunari T, Yamazaki M, Nakajima N, Kondo K, Fujimoto S, Inoue T, Iwanaga T, Terasawa Y, Shibazaki K, Kono Y, Nakajima M, Nakajima M, Mishina M, Adachi K, Imafuku I, Nomura K, Nagao T, Yaguchi H, Okamoto S, Osaki M, Kimura K.Characteristics of Ischemic Versus Hemorrhagic Stroke in Patients Receiving Oral Anticoagulants: Results of the PASTA Study. Intern Med. 2022;61:801-810

 

  1. Tahara N, Lairez O, Endo J, Okada A, Ueda M, Ishii T, Kitano Y, Lee H, Russo E, Kubo T. 99mTechnetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy. ESC Heart Fail. 2022;9:251-262

 

  1. Takamatsu K, Nakane S. Autonomic manifestations in autoimmune encephalitis. Neurol Clin Neurosci. 2022;10:130-136

 

  1. Takashio S, Yamada T, Nishi M, Morioka M, Nakashima N, Hirakawa K, Hanatani S, Usuku H, Yamamoto E, Ueda M, Matsushita K, Kaikita K, Tsujita K. Sex-related differences in the clinical characteristics of wild-type transthyretin amyloidosis cardiomyopathy. J Cardiol. 2022;79:50-57

 

  1. Tanaka T, Fukuma K, Abe S, Matsubara S, Motoyama R, Mizobuchi M, Yoshimura H, Matsuki T, Manabe Y, Suzuki J, Ikeda S, Kamogawa N, Ishiyama H, Kobayashi K, Shimotake A, Nishimura K, Onozuka D, Koga M, Toyoda K, Murayama S, Matsumoto R, Takahashi R, Ikeda A, Ihara M; PROPOSE Study Investigators. Antiseizure medications for post-stroke epilepsy: A real-world prospective cohort study. Brain Behav. 2021;11:e2330

 

  1. Tasaki M, Lavatelli F, Obici L, Obayashi K, Miyamoto T, Merlini G, Palladini G, Ando Y, Ueda M. Age-related amyloidosis outside the brain: A state-of-the-art review. Ageing Res Rev. 2021;70:101388

 

  1. Tasaki M, Oishi T, Ueda M. EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) amyloid deposits in the lower rectum from aged patient with bloody stools. Pathol Int. 2022;72:217-218

 

  1. Tasaki M, Okada M, Yanagisawa A, Nomura T, Matsushita H, Ueda A, Inoue Y, Masuda T, Misumi Y, Yamashita T, Nakamura T, Miyamoto T, Obayashi K, Ando Y, Ueda M. Apolipoprotein AI amyloid deposits in the ligamentum flavum in patients with lumbar spinal canal stenosis. Amyloid. 2021;28:107-112

 

  1. Tawara N, Nakane S, Kudo N, Kosaka T, Takamatsu K, Wada K, Kobayashi A, Yamashita S, Funagura N, Inoue T, Ando Y. Binasal hemianopia caused by bilateral optic perineuritis due to sarcoidosis. eNeurologicalSci. 2021;24:100354

 

  1. Tawara N, Yamashita S, Nagatoshi C, Nakajima M, Ichimura Y, Okiyama N, Ando Y. Anti-NXP2 antibody-positive dermatomyositis with aortic thrombus in normal aortic wall. Rheumatology. 2021;60:e159-e161

 

  1. Tawara N, Yamashita S, Takamatsu K, Yamasaki Y, Mukaino A, Nakane S, Farshadyeganeh P, Ohno K, Ando Y. Efficacy of salbutamol monotherapy in slow-channel congenital myasthenic syndrome caused by a novel mutation in CHRND. Muscle Nerve. 2021;63:e30-e32

 

  1. Tsukamoto Y, Tasaki M,* Fujii H, Tsujie M, Ueda M. EGF-containing fibulin-like extracellular matrix protein 1 amyloid incidentally found in surgically resected specimens of colon cancer: a case report emphasizing on an unrecognized type. Amyloid, 2021;28:136-137.

 

  1. Waddington-Cruz M, Ando Y, Amass L, Kiszko J, Chapman D, Sekijima Y. Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS). J Peripher Nerv Syst. 2021;26:160-166

 

  1. Waddington-Cruz M, Wixner J, Amass L, Kiszko J, Chapman D, Ando Y. Characteristics of patients with late- vs. early-Onset Val30Met transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey (THAOS) Neurol Ther. 2021;10:753-766

 

  1. Yamakawa M, Nakahara K, Nakanishi T, Nomura T, Ueda M. Miller Fisher syndrome following vaccination against SARS-CoV-2: a case report. Intern Med. 2022;61:1067-1069

 

  1. Yamakawa M, Watari M, Torii K, Kuki I, Miharu M, Kawazu M, Mukaino A, Higuchi O, Maeda Y, Ikeda T, Takamatsu K, Tawara N, Nakahara K, Matsuo H, Ueda M, Takahashi T, Nakane S. gAChR antibodies in children and adolescents with acquired autoimmune dysautonomia in Japan. Ann Clin Transl Neurol. 2021;8:790-799

 

  1. Yumoto S, Doi K, Higashi T, Shimao Y, Ueda M, Ishihara A, Adachi Y, Ishiodori H, Honda S, Baba H. Intra-abdominal bleeding caused by amyloid transthyretin amyloidosis in the gastrointestinal tract: a case report. Clin J Gastroenterol. 2022;15:140-145
Copyright© Department of Neurology, Graduate School of Medical Sciences, Kumamoto University.